Literature DB >> 2368100

Spontaneous improvement after acute ischemic stroke. A pilot study.

J Biller1, B B Love, E E Marsh, M P Jones, L E Knepper, D Jiang, H P Adams, D L Gordon.   

Abstract

Recent clinical studies emphasize the importance of early (less than 12 hours after onset) treatment of patients with acute ischemic stroke. Therapies have been proposed as being effective because of early clinical improvement. The frequency and degree of spontaneous improvement in such patients, however, is unknown. We prospectively evaluated the course of 29 patients (19 men, 10 women) aged 33-82 years who were seen less than or equal to 12 hours after the onset of acute ischemic stroke. Seventeen patients were first evaluated less than or equal to 6 hours and the remaining patients at 6-12 hours after onset. All patients were examined using a modified National Institutes of Health Stroke Scale at baseline, 1, 2, 3, and 6 hours. No specific treatment for acute ischemic stroke was given during this time. Improvement (defined as a decrease of greater than or equal to 2 points from baseline score) was noted at 1 hour in seven patients (24%). By 6 hours 15 patients (52%) had improved, 12 (41%) were unchanged, and two (7%) were worse. Our results suggest that spontaneous, often dramatic improvement occurs in patients with acute ischemic stroke and should be taken into consideration in the design of any trial of acute treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2368100     DOI: 10.1161/01.str.21.7.1008

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome.

Authors:  A E Baird; M C Austin; W J McKay; G A Donnan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-07       Impact factor: 10.154

Review 2.  Current management of ischaemic stroke.

Authors:  R S Marshall; J P Mohr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-01       Impact factor: 10.154

Review 3.  Thrombolytic therapy. From myocardial to cerebral infarction. The MAST-I Group. Multicentre Acute Stroke Trial.

Authors:  L Candelise; C Roncaglioni; E Aritzu; A Ciccone; A P Maggioni
Journal:  Ital J Neurol Sci       Date:  1996-02

4.  Treatment for Patients with Acute Ischemic Stroke Presenting beyond Six Hours of Ischemic Symptom Onset : Effectiveness of Intravenous Direct Thrombin Inhibitor, Argatroban.

Authors:  Jung Soo Park; Seung Soo Park; Eun Jeong Koh; Jong Pil Eun; Ha Young Choi
Journal:  J Korean Neurosurg Soc       Date:  2010-04-30

5.  Relationship between neurologic deficit severity and final functional outcome shifts and strengthens during first hours after onset.

Authors:  Jeffrey L Saver; Hernan Altman
Journal:  Stroke       Date:  2012-04-05       Impact factor: 7.914

6.  A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke.

Authors:  F Federico; V Lucivero; P Lamberti; A Fiore; C Conte
Journal:  Ital J Neurol Sci       Date:  1991-12

7.  Prognostic use of ultrasonography in acute non-hemorrhagic carotid stroke.

Authors:  M Camerlingo; L Casto; B Censori; M C Servalli; B Ferraro; A Mamoli
Journal:  Ital J Neurol Sci       Date:  1996-06

8.  Transcranial Magnetic Stimulation and Diffusion Tensor Tractography for Evaluating Ambulation after Stroke.

Authors:  Bo-Ram Kim; Won-Jin Moon; Hyuntae Kim; Eunhwa Jung; Jongmin Lee
Journal:  J Stroke       Date:  2016-05-31       Impact factor: 6.967

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.